G Cecchi

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Sclerosing Cholangitis after Continuous Hepatic Artery Infusiori of FUDR

M. Margaret Kemeny, Hector Battifora, Douglas W. Blayney et al. · Annals of Surgery · 1985 · 163 citations · Full text

Medicine, Internal Medicine, Surgery +13

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

Rowena Yip, Dorith Shaham, Steven Markowitz et al. · Radiology · 2023 · 72 citations · Full text

Medicine, Oncology, Radiation Oncology +15

High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.

M Bertrand, James H. Doroshow, P Multhauf et al. · Journal of Clinical Oncology · 1986 · 40 citations

Medicine, Oncology, Pharmacotherapy +17